Skip to main content
COR
NYSE Life Sciences

Cencora Raises Annual Profit Forecast Above Estimates Despite Q2 Revenue Miss

Tom Rudovsky · Reported by Reuters
More coverage: Healthcare
Sentiment info
Positive
Importance info
8
Price
$288
Mkt Cap
$59.507B
52W Low
$271
52W High
$377.54
52W Position info
6.3% above low
Off High info
24% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

COR is trading near its 52-week low of $271 (6.3% above the low).

Summary

Cencora (COR) reported second-quarter results that missed Wall Street estimates for both revenue ($78.4 billion vs $81.09 billion expected) and adjusted EPS ($4.75 vs $4.81 expected). Despite this, the company significantly raised its full-year profit forecast to $17.65-$17.90 per share, exceeding its previous guidance and analyst expectations of $17.60 per share. This positive outlook is attributed to robust demand for high-margin specialty medicines and GLP-1 drugs, alongside strategic divestitures and acquisitions aimed at strengthening its core drug distribution business. While the quarterly miss is a minor negative, the raised annual guidance provides a strong forward-looking positive signal for the company's profitability, indicating management's confidence in future performance. Peer Cardinal Health (CAH) also recently raised its profit forecast despite a revenue miss.

At the time of this announcement, COR was trading at $288.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $59.5B. The 52-week trading range was $271.00 to $377.54. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

COR - Latest Insights

COR
Nov 13, 2026, 11:43 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $356.14
Real-time Price: $339.83 info
Change: -$16.31 (-5%) info
Market Cap: $64.931B info
COR
Nov 04, 2026, 9:25 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $345.75
Real-time Price: $339.83 info
Change: -$5.92 (-2%) info
Market Cap: $64.931B info
COR
Nov 04, 2026, 6:37 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $342.67
Real-time Price: $339.83 info
Change: -$2.84 (-0.83%) info
Market Cap: $64.931B info
COR
Nov 04, 2026, 6:35 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $343.67
Real-time Price: $339.83 info
Change: -$3.84 (-1%) info
Market Cap: $64.931B info
COR
Oct 21, 2026, 7:48 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $342.51
Real-time Price: $339.83 info
Change: -$2.68 (-0.78%) info
Market Cap: $64.931B info